Daiichi Sankyo announces UK digital AF collaboration
Daiichi Sankyo has announced a collaboration with three technology partners to improve timely detection and diagnosis of atrial fibrillation (AF), the cause of one in five strokes in the UK.
The Japanese pharma said it will work with FibriCheck, neoHealthTech Limited and Capitol Healthcare on the scheme.
Together the partners will work on digital solutions to prevent AF, which if adequately detected and treated, could prevent around 7,000 strokes in England alone.
The partnership will aim to create a remote end-to-end detection system for the NHS, something that is currently unavailable.’
It will aim to bring detection and diagnosis of AF into patients’ homes allowing patients to get access to the right treatments on time.
The technologies, which consist of a smartphone application and wearable echocardiogram monitoring device, will allow NHS patients with a suspected arrhythmia to be monitored remotely, enabling the detection and diagnosis for otherwise hard-to-reach patients.
A core objective of this project is to support delivery of the NHS’ Long Term Plan objectives to provide digital solutions for patients, enabling them greater control over their health and the care they receive, while meeting the objectives of preventing 150,000 cardiovascular events by 2028.
Several integrated projects will be delivered in pilot areas in primary care networks across the UK throughout 2021 and 2022, which will provide local data on the efficacy and outcomes of the programme.
Capitol Medicare said is can provide data that can be analysed within 24 hours of an extended Holter test, which can produce a downloadable report that is ready immediately after analysis and provide recommendations for further treatment.
neoHealthTech will provide monitoring technology called QardioCore, which will allow clinicians to monitor patients in real time with a wearable kit.
FibriCheck will provide the smartphone technology that will provide the virtual care pathway and link the other two elements together, while also providing patients with tips about how to manage their condition.
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.